Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gadopentetate dimeglumine 469.01mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
gadopentetatdimeglumin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
1 |
dimeglumingadopentetat opløsning til enteral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|
dimeglumingadopentetat 1,876 mg/ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine (substance) |
Inferred relationship |
Some |
|